14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:PTIE
Delisted

Pain Therapeutics Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$40.17
+0 (+0%)
At Close: Aug 17, 2022
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 17th Aug 2022 PTIE stock ended at $40.17. During the day the stock fluctuated 0% from a day low at $40.17 to a day high of $40.17.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Pain Therapeutics prices

Date Open High Low Close Volume
Feb 16, 2022 $48.75 $49.38 $47.25 $48.76 654 808
Feb 15, 2022 $49.21 $51.14 $48.51 $49.22 933 681
Feb 14, 2022 $50.35 $51.45 $48.31 $48.70 1 210 946
Feb 11, 2022 $56.49 $56.49 $48.50 $51.01 2 916 863
Feb 10, 2022 $47.75 $62.49 $47.50 $53.05 9 238 616
Feb 09, 2022 $46.51 $49.64 $46.51 $49.22 1 371 459
Feb 08, 2022 $46.67 $47.42 $44.52 $47.12 928 777
Feb 07, 2022 $47.65 $48.89 $46.31 $47.04 1 233 846
Feb 04, 2022 $45.55 $49.00 $44.73 $47.81 1 699 669
Feb 03, 2022 $44.14 $46.43 $43.96 $45.08 858 660
Feb 02, 2022 $45.83 $46.55 $44.16 $45.73 1 418 335
Feb 01, 2022 $44.12 $49.75 $42.90 $46.01 2 893 556
Jan 31, 2022 $40.03 $45.49 $39.84 $44.25 1 741 537
Jan 28, 2022 $37.55 $39.96 $36.51 $39.75 1 362 485
Jan 27, 2022 $40.54 $40.70 $37.43 $37.66 946 932
Jan 26, 2022 $41.00 $41.49 $38.32 $39.45 1 343 505
Jan 25, 2022 $37.94 $41.08 $37.65 $40.02 1 085 981
Jan 24, 2022 $33.82 $39.78 $33.50 $39.54 2 874 934
Jan 21, 2022 $36.62 $37.60 $35.00 $36.33 2 476 148
Jan 20, 2022 $40.87 $41.95 $36.90 $37.41 2 676 229
Jan 19, 2022 $42.00 $42.97 $40.04 $41.17 1 532 944
Jan 18, 2022 $44.69 $44.76 $41.33 $41.48 2 305 666
Jan 14, 2022 $44.93 $46.43 $44.10 $45.88 1 413 152
Jan 13, 2022 $48.15 $49.12 $45.10 $45.69 1 554 843
Jan 12, 2022 $49.34 $49.95 $47.42 $48.49 1 843 430
Click to get the best stock tips daily for free!

About Pain Therapeutics

Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The company’s lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimer’s disease and other neurological disorders. The company was founded i... PTIE Profile

Golden Star

Ticker Date Change Price
VCSH May 03 0.0130% $76.93
BNDX May 03 0.349% $48.68
BBCA May 03 1.26% $65.44
ISTB May 03 0.0425% $47.11
ADTH May 03 5.56% $3.24
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT